To assess the potency of S100A8/A9 as a biomarker to predict the disease activity of DM-ILD, we analyzed the relationship between S100A8/A9 levels and their HRCT score or lung functions in DM-ILD patients. This evidence concerns the gene S100A8 and interstitial lung disease.